The Role ofPsychedelics in Managing Anxiety, Depression, and Flashbacks of Individuals withPost-Traumatic Stress Disorder
International Journal of Science and Research Methodology – January 31, 2022
Source: OpenAlex
Summary
A compelling review reveals psilocybin's significant therapeutic potential for traumatic stress, marking a paradigm shift in Psychiatry. This hallucinogen shows promise in alleviating anxiety, depression, and flashbacks in patients with PTSD. Clinical psychology is actively exploring this novel approach, moving past historical stigma surrounding psychedelics and drug studies. Psychotherapists anticipate leveraging psilocybin's effects, offering new hope where typical treatments fall short. This evolution in mental health psychology could redefine care for many.
Abstract
Background: The impact of psychedelic treatment on patients with posttraumatic stress disorder (PTSD) has become more intriguing to the psychiatric field. Because of the stigma surrounding illicit drug use, the scientific communities were unable to conduct thorough studies regarding the effects of psychedelics on the brain. These drugs could help many people with mental illnesses that have not found adequate success with typical treatments. In recent years, there have been studies conducted to examine the use of psychedelics for the treatment of psychiatric disorders such as PTSD. Purpose: The purpose of this review was to bring awareness to the effectiveness of long-forbidden psychedelic treatments such as psilocybin. Method: Using a review of scholarly articles, this paper examines the effects of psilocybin on anxiety, depression, and flashbacks in patients with PTSD. Findings: Findings indicate a therapeutic effect on patients with PTSD when using psilocybin. Conclusion: Based on these findings, the medical community should take steps toward novelty treatments for psychiatric diagnoses; however, further studies may be implicated. Stigma against this class of medications remains an issue.